Cases & Deals

  • Home
  • Practices
  • Axion BioSystems completes sale of company to Summa Equity

Share

Axion BioSystems completes sale of company to Summa Equity

July 2021

Client(s) Axion Biosystems, Inc.

Jones Day advised Axion BioSystems, Inc., a leading provider of MEA and impedance technology for single-cell analysis, in its sale of the company to Summa Equity.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.